Abstract
Erdheim-Chester Disease (ECD) is a rare form of non-Langerhans-
cell histiocytosis. Since its first description in 1930 by Jakob Erdheim
and William Chester, approximately 1500 cases have been reported
world-wide. Despite the majority of literature comprised by case
reports, a predilection for males in their 5th and 7th decade of life with
multisystem involvement that may include dermatologic systems,
central nervous system, skeletal, cardiovascular, renal systems have
been frequently reported. The presenting symptoms most commonly
include fatty nodules on the eyelids (xanthelasma) and cutaneous
xanthomas-like lesions of the skin, proptosis, diabetes insipidus,
dysarthria, headache, lower extremity bone pain and imbalance,
although many others have been described.
cell histiocytosis. Since its first description in 1930 by Jakob Erdheim
and William Chester, approximately 1500 cases have been reported
world-wide. Despite the majority of literature comprised by case
reports, a predilection for males in their 5th and 7th decade of life with
multisystem involvement that may include dermatologic systems,
central nervous system, skeletal, cardiovascular, renal systems have
been frequently reported. The presenting symptoms most commonly
include fatty nodules on the eyelids (xanthelasma) and cutaneous
xanthomas-like lesions of the skin, proptosis, diabetes insipidus,
dysarthria, headache, lower extremity bone pain and imbalance,
although many others have been described.
Original language | American English |
---|---|
State | Published - Sep 12 2020 |
Event | Inaugural 2020 San Diego Dermatology Symposium - San Diego, United States Duration: Sep 11 2020 → Sep 13 2020 |
Conference
Conference | Inaugural 2020 San Diego Dermatology Symposium |
---|---|
Country/Territory | United States |
City | San Diego |
Period | 9/11/20 → 9/13/20 |
Disciplines
- Medicine and Health Sciences